Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit

Using computer modelling, we have identified some of the residues of the A subunit of cholera toxin (CT) and heat-labile toxin that are involved in NAD binding, catalysis, and toxicity. Here we describe the site-directed mutagenesis of the CT gene and the construction of CT mutants. Nine mutations of the A subunit gene were generated. Six of them encoded proteins that were fully assembled in the AB5 structure and were nontoxic; these proteins were CT-D53 (Val-53-->Asp), CT-K63 (Ser-63-->Lys), CT-K97 (Val-97-->Lys), CT-K104 (Tyr-104-->Lys), CT-S106 (Pro-106-->Ser), and the double mutant CT-D53/K63 (Val-53-->Asp, Ser-63-->Lys). Two of the mutations encoded proteins that were assembled into the AB5 structure but were still toxic; these proteins were CT-H54 (Arg-54-->His) and CT-N107 (His-107-->Asn). Finally, one of the mutant proteins, CT-E114 (Ser-114-->Glu), was unable to assemble the A and the B subunits and produced only the B oligomer. The six nontoxic mutants were purified from the culture supernatants of recombinant Vibrio cholerae strains and further characterized. The CT-K63 mutant, which was the most efficient in assembly of the AB5 structure, was used to immunize rabbits and was shown to be able to induce neutralizing antibodies against both the A and B subunits. This molecule may be useful for the construction of improved vaccines against cholera.

[1]  R. Rappuoli,et al.  A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit , 1994, The Journal of experimental medicine.

[2]  C. Chelala,et al.  Cholera is walking south. , 1994, JAMA.

[3]  R. Rappuoli,et al.  Probing the structure‐activity relationship of Escherichia coli LT‐A by site‐directed mutagenesis , 1994, Molecular microbiology.

[4]  R. Rappuoli,et al.  Common features of the NAD‐binding and catalytic site of ADP‐ribosylating toxins , 1994, Molecular microbiology.

[5]  C. Locht,et al.  Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxin , 1994, Infection and immunity.

[6]  V. Rich.  Cholera in Russian Federation , 1994, The Lancet.

[7]  M. Waldor,et al.  Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. , 1994, The Journal of infectious diseases.

[8]  W. N. Burnette,et al.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs. , 1994, Infection and immunity.

[9]  M. Levine,et al.  Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Martial,et al.  Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.

[11]  N. Bean,et al.  Epidemic cholera in Ecuador: multidrug–resistance and transmission by water and seafood , 1994, Epidemiology and Infection.

[12]  Cholera. Update, end of 1993. , 1994, Releve epidemiologique hebdomadaire.

[13]  M. Lebens,et al.  Large-Scale Production of Vibrio cholerae Toxin B Subunit for Use in Oral Vaccines , 1993, Bio/Technology.

[14]  Suharyono,et al.  Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children. , 1993, The Journal of infectious diseases.

[15]  B. Mandal.  Epidemic cholera due to a novel strain of V. cholerae non-01--the beginning of a new pandemic? , 1993, The Journal of infection.

[16]  Y. Takeda,et al.  Outbreak of Vibrio cholerae non-01 in India and Bangladesh , 1993, The Lancet.

[17]  T. Sixma,et al.  Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. , 1993, Journal of molecular biology.

[18]  B. Spangler,et al.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. , 1992, Microbiological reviews.

[19]  D. Sack,et al.  An oral B subunit: whole cell vaccine against cholera. , 1992, Vaccine.

[20]  A. Siitonen,et al.  Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine , 1991, The Lancet.

[21]  W. N. Burnette,et al.  Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity , 1991, Infection and immunity.

[22]  M. Noda,et al.  Glutamic acid‐112 of the A subunit of heat‐labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP‐ribosyltransferase activity , 1991, FEBS letters.

[23]  Y. Lobet,et al.  Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin , 1991, Infection and immunity.

[24]  T. Sixma,et al.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli , 1991, Nature.

[25]  T. Nagamine,et al.  H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. , 1991, Immunology.

[26]  Gill Dm,et al.  Cholera toxin-catalyzed [32P]ADP-ribosylation of proteins. , 1991 .

[27]  Research priorities for diarrhoeal disease vaccines: memorandum from a WHO meeting. , 1991, Bulletin of the World Health Organization.

[28]  K. Okamoto,et al.  A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity. , 1990, The Journal of biological chemistry.

[29]  R. Rappuoli,et al.  The subunit S1 is important for pertussis toxin secretion. , 1990, The Journal of biological chemistry.

[30]  T G Cleary,et al.  Intestinal electrolyte transport and diarrheal disease. , 1990, The New England journal of medicine.

[31]  C. Dykes,et al.  Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene. , 1989, European journal of biochemistry.

[32]  C. Tacket,et al.  SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR , 1988, The Lancet.

[33]  D. Sack,et al.  Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. , 1988, The Journal of infectious diseases.

[34]  M U Khan,et al.  Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. , 1988, The Journal of infectious diseases.

[35]  T. Miwatani,et al.  Effect of substitution of glycine for arginine at position 146 of the A1 subunit on biological activity of Escherichia coli heat-labile enterotoxin , 1988, Journal of bacteriology.

[36]  J. Mekalanos.  [24] Production and purification of cholera toxin , 1988 .

[37]  J. Mekalanos.  Production and purification of cholera toxin. , 1988, Methods in enzymology.

[38]  C. Jacob,et al.  Epitopes of the cholera family of enterotoxins. , 1987, Reviews of infectious diseases.

[39]  M. Levine,et al.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin , 1987, Infection and immunity.

[40]  D. Sack,et al.  An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial. , 1987, Advances in experimental medicine and biology.

[41]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[42]  J. Mekalanos,et al.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development , 1983, Nature.

[43]  R. Holmes,et al.  Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits , 1983, Infection and immunity.

[44]  J. Holmgren,et al.  Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin , 1983, Infection and immunity.

[45]  R. Cortese,et al.  pEMBL: a new family of single stranded plasmids. , 1983, Nucleic acids research.

[46]  M. Smith,et al.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. , 1982, Nucleic acids research.

[47]  R. Colwell,et al.  Production and characterization of monoclonal antibodies to cholera toxin , 1982, Infection and immunity.

[48]  J. Mekalanos,et al.  Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Lai,et al.  ADP-ribosyl transferase activity of cholera toxin polypeptide A1 and the effect of limited trypsinolysis. , 1981, Biochemical and biophysical research communications.

[50]  A. Kurosky,et al.  Antigenic Specificity of Neutralizing Antibody to Cholera Toxin , 1979, Infection and immunity.

[51]  J. Holmgren,et al.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid , 1976, Infection and immunity.

[52]  B. A. Rubin,et al.  Development of a Purified Cholera Toxoid I. Purification of Toxin , 1974, Infection and immunity.

[53]  B. A. Rubin,et al.  Development of a Purified Cholera Toxoid II. Preparation of a Stable, Antigenic Toxoid by Reaction of Purified Toxin with Glutaraldehyde , 1974, Infection and immunity.

[54]  S. Donta,et al.  Detection of Heat-Labile Escherichia coli Enterotoxin with the Use of Adrenal Cells in Tissue Culture , 1974, Science.